Education
About Us
Working with TipRanks
Follow Us
Korro Bio, Inc. (KRRO)
:KRRO
Total Valuation
Korro Bio has a market cap or net worth of $150.15M. The enterprise value is $64.56M.
Market Cap$150.15M
Enterprise Value$64.56M
Share Statistics
Korro Bio has 9,390,903 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,390,903
Owned by Insiders31.95%
Owned by Institutions0.02%
Financial Efficiency
Korro Bio’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -43.05%.
Return on Equity (ROE)-0.52
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-43.05%
Return on Capital Employed (ROCE)-0.44
Revenue Per Employee20.28K
Profits Per Employee-746.26K
Employee Count112
Asset Turnover0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Korro Bio is ―. Korro Bio’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value2.12
Price to FCF―
Price to Operating Cash Flow-2.64
PEG Ratio―
Income Statement
In the last 12 months, Korro Bio had revenue of 2.27M and earned -83.58M in profits. Earnings per share was -9.37.
Revenue2.27M
Gross Profit2.27M
Operating Income-91.91M
Pretax Income-83.44M
Net Income-83.58M
EBITDA-88.34M
Earnings Per Share (EPS)-9.37
Cash Flow
In the last 12 months, operating cash flow was -67.27M and capital expenditures -6.59M, giving a free cash flow of -73.86M billion.
Operating Cash Flow-67.27M
Free Cash Flow-73.86M
Free Cash Flow per Share-7.86
Dividends & Yields
Korro Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.18
52-Week Price Change-54.73%
50-Day Moving Average14.19
200-Day Moving Average27.62
Relative Strength Index (RSI)69.13
Average Volume (3m)120.11K
Important Dates
Korro Bio upcoming earnings date is Nov 18, 2025, Before Open (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date―
Financial Position
Korro Bio as a current ratio of 8.79, with Debt / Equity ratio of 38.78%
Current Ratio8.79
Quick Ratio8.79
Debt to Market Cap<0.01
Net Debt to EBITDA0.12
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Korro Bio has paid 141.00K in taxes.
Income Tax141.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Korro Bio EV to EBITDA ratio is -3.72, with an EV/FCF ratio of -4.22.
EV to Sales144.75
EV to EBITDA-3.72
EV to Free Cash Flow-4.22
EV to Operating Cash Flow-5.47
Balance Sheet
Korro Bio has $96.36M in cash and marketable securities with $44.63M in debt, giving a net cash position of -$51.73M billion.
Cash & Marketable Securities$96.36M
Total Debt$44.63M
Net Cash-$51.73M
Net Cash Per Share-$5.51
Tangible Book Value Per Share$17.98
Margins
Gross margin is 67.12%, with operating margin of -4047.12%, and net profit margin of -3680.36%.
Gross Margin67.12%
Operating Margin-4047.12%
Pretax Margin-3674.15%
Net Profit Margin-3680.36%
EBITDA Margin-3890.14%
EBIT Margin-4047.12%
Analyst Forecast
The average price target for Korro Bio is $100.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$100.50
Price Target Upside430.90% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast61.73%